4//SEC Filing
ROBERTSON MICHELLE 4
Accession 0001415889-23-000875
CIK 0001650664other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 4:30 PM ET
Size
5.4 KB
Accession
0001415889-23-000875
Insider Transaction Report
Form 4
ROBERTSON MICHELLE
Chief Financial Officer
Transactions
- Sale
Common Stock
2023-01-10$8.16/sh−1,752$14,296→ 80,530 total
Footnotes (2)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on December 30,2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on January 9,2023. The sale does not represent a discretionary trade by the Reporting Person.
- [F2]This transaction was executed in multiple trades at prices ranging from $8.1600 to $8.1911. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001755098
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 4:30 PM ET
- Size
- 5.4 KB